Israel Englander Acadia Pharmaceuticals Inc Call Options Transaction History
Millennium Management LLC
- $224 Billion
- Q1 2024
Call Options
1 transactions
Others Institutions Holding ACAD
# of Institutions
299Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$679 Million10.04% of portfolio
-
Rtw Investments, LP New York, NY13.8MShares$219 Million4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$211 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$185 Million0.01% of portfolio
-
State Street Corp Boston, MA6MShares$95.1 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.56B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...